Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Antonen, J. A.
Right arrow Articles by Saha, H. H. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antonen, J. A.
Right arrow Articles by Saha, H. H. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 777-781
© 2003 European Renal Association-European Dialysis and Transplant Association

Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults

Jaakko A. Antonen1,, Reijo Pyhälä2, Päivi M. Hannula1, Ilpo O. Ala-Houhala1, Riitta Santanen2, Niina Ikonen2 and Heikki H. T. Saha1

1 Department of Medicine, Tampere University Hospital and Medical School, University of Tampere, Tampere and 2 Influenza Laboratory, National Public Health Institute, Helsinki, Finland

Background. Annual influenza vaccination is recommended for patients with chronic renal failure, although vaccination responses in haemodialysis (HD) patients may be suboptimal. Typically, the seroreactivity has been analysed against the vaccine virus or the corresponding year's epidemic virus. No studies analysing cross-reactivity against subsequent years' viruses have been presented.

Methods. Twenty-three chronic HD patients and 26 cardiac patients were, in autumn 1995, vaccinated with a trivalent influenza vaccine. The cross-reacting haemagglutination-inhibiting antibodies to five consecutive years' (the last season 1999–2000) drift variants of H3N2 subtype influenza A virus were measured and compared with those of vaccinated cardiac patients and with those of 26 healthy military conscripts who suffered a serologically confirmed influenza A infection in the season 1995–1996.

Results. The influenza vaccination in HD patients resulted in comparable cross-reacting antibodies to the antibodies induced both by vaccination in cardiac patients and by natural infection in military conscripts. After a steady decline, the cross-reactivity to the latest epidemic virus improved in all the groups. This may be due to two reverted amino acid changes in the HA1 domain of the virus haemagglutinin.

Conclusions. Influenza vaccination in HD patients is as effective as the vaccination of cardiac patients with normal kidney function. The cross-reactivity of vaccination-induced antibodies is even as good as that of antibodies induced by natural infection of young healthy males. Additionally, vaccination seems to prime the individual beneficially against subsequent years' influenza viruses.

Keywords: cross-reactivity; haemodialysis; influenza; vaccination; vitamin D

Correspondence and offprint requests to: Jaakko Antonen, Medical School, FIN-33014 University of Tampere, Finland. Email: jaakko.antonen{at}uta.fi


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Davies, O. Carlsson, O. Simonsen, A.-C. Johansson, D. Venturoli, I. Ledebo, A. Wieslander, C. Chan, and B. Rippe
The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1609 - 1617.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Janus, L.-V. Vacher, S. Karie, E. Ledneva, and G. Deray
Vaccination and chronic kidney disease
Nephrol. Dial. Transplant., March 1, 2008; 23(3): 800 - 807.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.